Mikael Totterman Email and Phone Number
Tech Entrepreneur | 2x Succesful Exit | 3x VC-Backed Founder | 2x AI/ML | BCG Alum | Dartmouth MBA | Stanford Engineering at
@
Clerio Vision, Inc.
Mikael Totterman's Location
Stateline, Nevada, United States, United States
Mikael Totterman's Contact Details
Mikael Totterman work email
- Valid
- Valid
- Valid
- Valid
- Valid
Mikael Totterman personal email
n/a
Mikael Totterman phone numbers
About Mikael Totterman
As a Founder and Chief Innovation Officer at Clerio Vision, I lead the development and commercialization of next-generation vision correction technologies that aim to improve the lives of millions of people with refractive errors. With over 25 years of experience in technology entrepreneurship, I have co-founded and grown three successful startups in the medical and software sectors, raising over $100 million in venture capital and corporate partnerships while generating over $500 million in exit value for investors and founders. The two successful software start-ups leveraged approaches to AI/ML complemented by human-in-the-loop oversight.My passion is to start by identifying and solving unmet needs, leveraging my strategy, product development, business development, and fundraising skills. I also leverage my extensive network and expertise to support and advise other startups and organizations in the MedTech, Cyber Security, and AI fields as the Managing Member at Stoneleigh Capital and Chairman of the Business Advisory Board at Atumcell Group. I hold an MBA from Dartmouth College and a BS in Management Science and Engineering from Stanford University.
Mikael Totterman's Current Company Details
Clerio Vision, Inc.
View
Tech Entrepreneur | 2x Succesful Exit | 3x VC-Backed Founder | 2x AI/ML | BCG Alum | Dartmouth MBA | Stanford Engineering
Mikael Totterman Work Experience Details
-
Founder, Chairman Of The Board And Chief Innovation OfficerClerio Vision, Inc. Sep 2019 - PresentWest Henrietta, New York, Us
-
Chief Executive OfficerClerio Vision, Inc. Mar 2015 - Sep 2019West Henrietta, New York, Us• Clerio Vision is developing a suite of revolutionary products for the vision care market based on an extensive portfolio of over 100 patents exclusively licensed from the University of Rochester. The technology has applications in next-generation contact lenses for presbyopia and myopia control, intraocular lenses as well as the global refractive surgery market. The presbyopia, myopia control, and non-invasive refractive surgery products are currently in clinical development.• Clerio's multifocal contact lenses have been shown to be superior to existing multifocal contact lenses in terms of visual acuity and visual quality. The lenses leverage optics that rely on the quantum properties of light.• Raised over $50 million in equity capital from leading venture capital firms, including Safar Partners, Norwest Venture Partners, Topmark Partners, and Armory Square Ventures.• Raised over $20 million for joint development programs from leading ophthalmic companies.
-
Managing MemberStoneleigh Capital Jan 2020 - Present• Family office focused on long-only strategy in public and private assets, including real estate, farmland, commodities and select PE/VC opportunities. -
Chairman Of Business Advisory BoardAtumcell Group Aug 2021 - PresentBoston , Ma, Us• Atumcell’s targeted risk assessment exposes emerging threats before they cause harm. Our cyber threat management solution provides the tools you need to stay a step ahead.• Atumcell provides leading-edge software, hardware, and services to solve complex cybersecurity problems for companies and government agencies in North America and Europe.• The approach is based on an algorithm-driven vulnerability assessment supported by human-in-the-loop use of GenAI for reporting. -
Founder And Board MemberIcardiac Feb 2006 - Nov 2017Philadelphia, Pennsylvania, Us• iCardiac Technologies, Inc., is the world’s largest dedicated ECG core laboratory serving the pharmaceutical industry. Its team of medical and scientific experts collectively bring over 100 years of cardiology, electrophysiology, drug development, medical device, regulatory and academic experience. iCardiac team members are active contributors on several FDA working groups that are advancing the field of cardiac safety. • iCardiac’s COMPAS platform maximizes the precision, accuracy, and decreases the cost of cardiac safety assessment from First-in-Human studies to Phase III studies including TQT studies. Due to the superior ECG analysis methods, iCardiac today is the leading provider of ECG core lab services for clinical trials by number of new TQT study awards. We offer industry’s most sophisticated, easy-to-use, small and portable ECG/Holter equipment for multi-site clinical trials, which allows the centralization of ECG and Holter data seamlessly over the Internet. All data is managed electronically, minimizing errors, data loss and reducing costs of data reconciliation. We are proud to be working with a large number of clinical sites globally.• In collaboration with the FDA and the pharmaceutical industry, iCardiac has validated several next generation tools, including High Precision QT, Early Precision QT, and QT-beat-to-beat, for improved characterization of cardiac safety in clinical trials. These tools involved various ML approaches, including ECG beat classification, fiducial detection, and mathematical modeling of cardiac hysteresis. -
CeoIcardiac Feb 2006 - Sep 2014Philadelphia, Pennsylvania, Us
-
ChairmanIcardiac Feb 2006 - Feb 2014Philadelphia, Pennsylvania, Us
-
Member - Flredc - Technology Commercialization & Business CreationEmpire State Development Sep 2014 - Sep 2017New York, Ny, Us• The New York State Regional Development Council supports efforts to translate the scientific discoveries and expertise of the region’s research universities and institutions of higher education into new generations of innovative products and companies. The Finger Lakes region leads upstate New York in external research funding – over the last five years, the University of Rochester and Rochester Institute of Technology (RIT) have attracted $2.1 billion – and possesses the technology commercialization infrastructure necessary to turn these discoveries into new commercial ventures. -
Co-Chair Life Sciences - FlredcEmpire State Development Jan 2013 - Jan 2014New York, Ny, Us• New York State is divided into 10 Regional Councils to develop long-term strategic plans for economic growth. These councils are public-private partnerships made up of local experts and stakeholders from business, academia, local government, and non-governmental organizations.
-
Director, Global Alliances3Com Dec 2004 - Feb 2006Marlborough, Ma, Us• Responsible for identifying, negotiating, and managing global go-to-market alliances to deploy 3Com products including Wireless LAN, VoIP, Intrusion Prevention, Routing and Switching from small to large enterprise markets.• Drove restructuring of internal processes including distribution, logistics, finance, marketing, and contracting to support global go-to-market alliances. Provided interface to Huawei-3Com Joint Venture for alliance partners as well as to 3Com’s newly acquired TippingPoint Intrusion Prevention Security Division to drive partnerships.• Established partnership with Philips to deploy 3Com’s full range of LAN, WAN and Security solutions with medium and large enterprise market. Achieved partnership by positioning 3Com’s product attributes in the medium enterprise “sweet-spot” – secure, reliable, cost-effective, easy-to-maintain, and feature rich. • Established partnership with BT PLC to focus on deployment of 3Com routing, switching, wireless and security solutions within the European Market to Small and Medium Size Enterprises. Coordinated all negotiations and launch activities.• Established AT&T partnership to deploy 3Com router solutions within medium/large enterprise market by supporting AT&T’s objective of integrating forward. • Coordinated product development feedback and presentations to AT&T, Siemens, Philips, and BT for next generation 3Com Open Services Router Platform. -
Acting Ceo, Svp And Chief Operating OfficerVirtualscopics, Inc (Now Part Of Biotelemetry Research) Jul 2001 - Nov 2004Rochester, Ny, Us• VirtualScopics is a publicly traded Pfizer, Inc. and GE Healthcare Portfolio Company focused on the development of analysis tools to better characterize the mechanisms of action and efficacy profiles of pharmaceutical compounds to accelerate clinical trials for pharmaceutical companies. The tools used a broad range of AI/ML methods, including statistical and morphological priors, directed clustering, covariance matrices, and maximum likelihood classifiers to detect and measure tissue types in two and three-dimensional medical images.• Managed entire organization across clinical trial project management, data management, data analysis, field operations, algorithm development, software development, and finance. • Structured partnership and equity investment with Pfizer, Inc. to pursue co-development of software-based imaging biomarkers to accelerate early stage development of Musculoskeletal, Inflammation, Oncology, Cardiovascular and Neurology compounds. • Structured partnership and equity investment with GE Health Care to pursue development of software based analytics complementary with GE’s diagnostic business in additional to promoting cross sales opportunities. -
Director3Com Ventures Jun 2000 - Jul 2001Marlborough, Ma, Us• One of three principals responsible for managing 3Com Ventures II, a $250 million venture fund focused on strategic networking and wireless transactions.• Responsible for overseeing timing of sale of liquid wireless stock portfolio from 3Com Ventures I, representing at total of over $300 million in value.• Worked with senior management team including CEO, CTO, and Chairman of the Board to develop investment thesis for closing key technology gaps in multiple networking sectors including personal, local and wide area networking.• Made investments in and managed relationships with Benchmark Europe and Broadview Ventures to improve deal flow in targeted technology areas.• Negotiated and managed investments in Silicon Wave (Bluetooth Silicon Provider acquired by RF Micro Devices), AirPrime (High Speed Wireless OEM acquired by Sierra Wireless), MeshNetworks (Mesh-Based Wireless Networking Provider acquired by Motorola), and Intransa (High Speed Storage Area Network Provider.)
-
ConsultantBoston Consulting Group Aug 1998 - Jan 2000Boston, Massachusetts, Us -
ConsultantGemini Consulting Aug 1993 - Jun 1996Za
Mikael Totterman Skills
Start Ups
Strategy
Entrepreneurship
Business Development
Venture Capital
Healthcare
Business Strategy
Strategic Planning
Management
Executive Management
Leadership
Project Management
Pharmaceutical Industry
Biotechnology
Strategic Partnerships
Medical Devices
Lifesciences
Commercialization
Clinical Trials
Analysis
Cross Functional Team Leadership
Fda
Life Sciences
Corporate Development
Mergers And Acquisitions
Business Alliances
Technology Transfer
Enterprise Software
Strategic Alliances
Clinical Research
Drug Development
Team Leadership
Product Management
Conversation
Go To Market Strategy
Clinical Development
Biopharmaceuticals
Competitive Analysis
Analytics
R&d
Regulatory Affairs
Data Analysis
Sales Management
Angel Investing
Strategic Leadership
Mikael Totterman Education Details
-
The Tuck School Of Business At DartmouthTechnology Concentration -
Stanford UniversityManagement Science And Engineering
-
Brighton High SchoolDiploma
Frequently Asked Questions about Mikael Totterman
What company does Mikael Totterman work for?
Mikael Totterman works for Clerio Vision, Inc.
What is Mikael Totterman's role at the current company?
Mikael Totterman's current role is Tech Entrepreneur | 2x Succesful Exit | 3x VC-Backed Founder | 2x AI/ML | BCG Alum | Dartmouth MBA | Stanford Engineering.
What is Mikael Totterman's email address?
Mikael Totterman's email address is mi****@****iac.com
What is Mikael Totterman's direct phone number?
Mikael Totterman's direct phone number is +158576*****
What schools did Mikael Totterman attend?
Mikael Totterman attended The Tuck School Of Business At Dartmouth, Stanford University, Brighton High School.
What skills is Mikael Totterman known for?
Mikael Totterman has skills like Start Ups, Strategy, Entrepreneurship, Business Development, Venture Capital, Healthcare, Business Strategy, Strategic Planning, Management, Executive Management, Leadership, Project Management.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial